Multiple bowel polyps
Gene: MSH2EnsemblGeneIds (GRCh38): ENSG00000095002
EnsemblGeneIds (GRCh37): ENSG00000095002
OMIM: 609309, Gene2Phenotype
MSH2 is in 37 panels
2 reviews
Ellen Thomas (Genomics England Curator)
Comment on list classification: Biallelic causes polyposis; monoallelic also relevant due to overlapping presentation between colorectal cancer and polyposis.Created: 29 Jan 2016, 4:39 p.m.
Ian Frayling (Cardiff University)
Only predisposes to multiple colorectal adenomas with biallelic mutations, i.e. Constitutional Mismatch Repair Disorder (CMMR-D)Created: 8 Dec 2015, 2:39 p.m.
Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Publications
- Wimmer, K., Kratz, C. P., Vasen, H. F., et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’(C4CMMRD). Journal of Medical Genetics 2014
- 51: 355-365.
Details
- Mode of Inheritance
- BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
- Sources
-
- Expert Review Green
- Eligibility statement prior genetic testing
- OMIM
- 609309
- Clinvar variants
- Variants in MSH2
- Penetrance
- Complete
- Publications
-
- Wimmer, K., Kratz, C. P., Vasen, H. F., et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’(C4CMMRD). Journal of Medical Genetics 2014
- 51: 355-365.
- Panels with this gene
-
- Multiple monogenic benign skin tumours
- Inherited polyposis and early onset colorectal cancer - germline testing
- Familial breast cancer
- Ovarian cancer pertinent cancer susceptibility
- Endometrial cancer pertinent cancer susceptibility
- Adult solid tumours cancer susceptibility
- Haematological malignancies cancer susceptibility
- Brain cancer pertinent cancer susceptibility
- Genodermatoses with malignancies
- Inherited pancreatic cancer
- Familial rhabdomyosarcoma
- Haematological malignancies for rare disease
- Pigmentary skin disorders
- Inherited MMR deficiency (Lynch syndrome)
- Inherited renal cancer
- Bladder cancer pertinent cancer susceptibility
- Childhood solid tumours cancer susceptibility
- Inherited ovarian cancer (without breast cancer)
- Familial Tumours Syndromes of the central & peripheral Nervous system
- Upper gastrointestinal cancer pertinent cancer susceptibility
- Sarcoma cancer susceptibility
- Endocrine neoplasia
- Prostate cancer pertinent cancer susceptibility
- Inherited prostate cancer
- Neurofibromatosis Type 1
- Colorectal cancer pertinent cancer susceptibility
- Adult solid tumours for rare disease
- Additional findings health related - CNV analysis adult specific
- Renal cancer pertinent cancer susceptibility
- GI tract tumours
- Sarcoma susceptibility
- Familial prostate cancer
- Additional findings health related - adult specific
- Childhood solid tumours
- Fetal anomalies
- Inherited non-medullary thyroid cancer
- Additional findings health related
History Filter Activity
Set publications
Ellen McDonagh (Genomics England Curator)Publications for MSH2 were set to Wimmer, K., Kratz, C. P., Vasen, H. F., et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’(C4CMMRD). Journal of Medical Genetics 2014; 51: 355-365.
Set Mode of Inheritance
Ellen McDonagh (Genomics England Curator)Mode of inheritance for MSH2 was changed to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Gene classified by Genomics England curator
Ellen Thomas (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Gene classified by Genomics England curator
Ellen Thomas (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Added New Source
Ellen McDonagh (Genomics England Curator)MSH2 was added to Multiple bowel polypspanel. Sources: Eligibility statement prior genetic testing